IBCA News Alert Intervest Bancshares (IBCA) 10.78 02/13/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intervest Bancshares (IBCA) 10.78 $IBCA

Shares of IBCA Up 38.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 11, 9:36AM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 14 months, Intervest Bancshares has returned 38.65% as of today's recent price of $10.78.
IBCA: 10.78 (+0.21)

Bank of the Ozarks, Inc. Completes Acquisition of Intervest Bancshares Corporation
Business Wire - Tue Feb 10, 4:00PM CST
Bank of the Ozarks, Inc. (NASDAQ: OZRK) announced today the completion of its acquisition of Intervest Bancshares Corporation ("Intervest" effective February 10, 2015 pursuant to a previously announced definitive agreement and plan of merger between Bank of the Ozarks, Inc. ("Company" and Intervest.
IBCA: 10.78 (+0.21), OZRK: 35.94 (-0.13)

Shares of IBCA Up 29.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 04, 9:12AM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 13 months, Intervest Bancshares has returned 29.90% as of today's recent price of $10.10.
IBCA: 10.78 (+0.21)

Intervest Bancshares Shares Up 28.9% Since SmarTrend's Buy Recommendation (IBCA)
Comtex SmarTrend(R) - Tue Jan 27, 4:59PM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 13 months, Intervest Bancshares has returned 28.87% as of today's recent price of $10.02.
IBCA: 10.78 (+0.21)

Intervest Bancshares Corporation Reports 2014 Fourth Quarter Earnings of $3.9 Million or $0.18 per share and Full Year 2014 Earnings of $17.7 Million or $0.80 per share
Business Wire - Tue Jan 20, 7:00AM CST
Intervest Bancshares Corporation (IBC) (NASDAQ-GS:IBCA), parent company of Intervest National Bank (INB), today announced that its net earnings available to common stockholders for the fourth quarter of 2014 (Q4-14) decreased slightly to $3.9 million, or $0.18 per share, from $4.2 million, or $0.19 per share, for the fourth quarter of 2013 (Q4-13). For the year 2014, net earnings available to common stockholders increased 32% to $17.7 million, or $0.80 per share, from $13.4 million, or $0.61 per share, for 2013.
IBCA: 10.78 (+0.21)

Intervest Bancshares declares dividend of USD0.05 per share for quarter
M2 - Wed Jan 07, 4:31AM CST
Intervest Bancshares Corporation (Nasdaq:IBCA), the holding company for Intervest National Bank, announced on Wednesday that it will pay a cash dividend of USD0.05 per share.
IBCA: 10.78 (+0.21)

Intervest Bancshares declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:22PM CST

IBCA: 10.78 (+0.21)

Intervest Bancshares Corporation Announces Quarterly Dividend
Business Wire - Tue Jan 06, 3:15PM CST
Intervest Bancshares Corporation (the "Company" (Nasdaq:IBCA), the holding company for Intervest National Bank, announced today the declaration of a cash dividend of $0.05 per share for holders of record as of January 16, 2015 and payable on January 26, 2015.
IBCA: 10.78 (+0.21)

Intervest Bancshares Up 29.1% Since SmarTrend Uptrend Call (IBCA)
Comtex SmarTrend(R) - Tue Jan 06, 9:14AM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 12 months, Intervest Bancshares has returned 29.13% as of today's recent price of $10.04.
IBCA: 10.78 (+0.21)

Bank of the Ozarks Hits 52-Week High on Growth Plans - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:50AM CST
Shares of Bank of the Ozarks, Inc. (OZRK) crafted a new 52-week high, touching $38.17 on Dec 31.
CUBI: 22.29 (-0.14), MBRG: 18.25 (unch), IBCA: 10.78 (+0.21), OZRK: 35.94 (-0.13)

Bank of the Ozarks announces closure of merger with Intervest Bancshares in February
M2 - Fri Jan 02, 4:35AM CST
Bank of the Ozarks Inc (NASDAQ:OZRK), a bank holding company, on Thursday jointly reported with Intervest Bancshares Corporation (NASDAQ:IBCA) that the earlier declared merger transaction will close on or about 10 February 2015.
IBCA: 10.78 (+0.21), OZRK: 35.94 (-0.13)

Bank of the Ozarks, Inc. and Intervest Bancshares Corporation Announce Expected Closing Date for Pending Merger
Business Wire - Wed Dec 31, 3:05PM CST
Bank of the Ozarks, Inc. ("Ozarks" (NASDAQ: OZRK) and Intervest Bancshares Corporation ("Intervest" (NASDAQ: IBCA) today jointly announced that the companies expect the previously announced merger transaction will close on or about February 10, 2015, subject to satisfaction of the remaining closing conditions set forth in the merger agreement, including the approval and adoption of the merger agreement by Intervest's stockholders at the special meeting of stockholders scheduled for January 27, 2015. All required regulatory approvals for the merger of Intervest with and into Ozarks have been received.
IBCA: 10.78 (+0.21), OZRK: 35.94 (-0.13)

Intervest Bancshares Has Returned 28.4% Since SmarTrend Recommendation (IBCA)
Comtex SmarTrend(R) - Fri Dec 12, 4:47PM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 12 months, Intervest Bancshares has returned 28.36% as of today's recent price of $9.98.
IBCA: 10.78 (+0.21)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Purlin's Patent: Transforming Real Estate Deals

Updated Category News Views 1

Purlin's Game-Changer: A Patent in Real Estate Real estate has been chugging along like a stubborn mule, dragging deals through opaque negotiations and haphazard guessing games. Then enters Final Offer from Purlin Enterprises, waving a newly granted patent like a shiny golden ticket to those stuck trading homes in the dark. Leveling the Playing Field with Transparency In...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 1

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 11

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 15

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 14

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Ball Corp's Leadership Shuffle Aims for Strategic Gains

Updated Category News Views 9

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 9

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 11

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading

Top 5 Most Recently Viewed Articles

Job Market Insights: Anticipation Builds as Reports Loom

Updated Category News Views 239

Overview of Upcoming Job Reports As the job market continues to be a significant focus for investors and economists alike, there is growing anticipation surrounding a crucial jobs report from the Bureau of Labor Statistics. Scheduled for release on Friday morning, this report is expected to shape economic forecasts and market reactions. What to Expect from the Jobs Report...

Continue Reading
Enterprise Financial Services Corp Announces Q4 Earnings Call Details

Updated Category News Views 96

Join the Upcoming Conference Call for Q4 2024 Earnings Enterprise Financial Services Corp (Nasdaq: EFSC) is set to announce its financial results for the fourth quarter of 2024. This eagerly anticipated release is scheduled for the final days of January. Finance enthusiasts and stakeholders are encouraged to tune into the conference call and webcast where they can gain...

Continue Reading
Wearable Devices Secures $4 Million in Innovative Funding

Updated Category News Views 224

Wearable Devices Announces Successful Funding Initiative Yokneam Illit, Israel – In a significant milestone, Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW), renowned for their groundbreaking artificial intelligence (AI) technology that powers touchless sensing wearables, has successfully initiated a securities purchase agreement. This agreement involves the sale of 670,000...

Continue Reading
Potential Growth for First Solar Stocks Amid Declining Price

Updated Category News Views 122

Firm Outlook as First Solar Prepares for Earnings Report First Solar Inc (NASDAQ: FSLR) is preparing to reveal its fourth-quarter earnings. Analysts predict earnings per share (EPS) to come in at $4.71, while overall revenues are expected to reach $1.47 billion. These figures are set to be announced after market hours, creating significant anticipation among investors....

Continue Reading
Candel Therapeutics Reports Promising Results for Cancer Treatment

Updated Category News Views 246

Candel Therapeutics Publishes Clinical Trial Findings In an exciting development for cancer treatment, Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company specializing in innovative immunotherapies, has announced the publication of their phase 1b clinical trial results. This landmark study investigated the safety and tolerability of...

Continue Reading